These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16259219)

  • 21. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
    Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adiponectin and atherosclerosis].
    Haluzíková D; Roubícek T; Haluzík M
    Vnitr Lek; 2007 Apr; 53(4):359-63. PubMed ID: 17578166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance.
    Tiwari A
    Curr Opin Investig Drugs; 2010 Apr; 11(4):385-93. PubMed ID: 20336586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin: a key adipocytokine in metabolic syndrome.
    Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
    Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
    Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K; Tobe K
    J Clin Invest; 2006 Jul; 116(7):1784-92. PubMed ID: 16823476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of obesity and insulin sensitivity on adiponectin isoform distribution.
    Kaser S; Tatarczyk T; Stadlmayr A; Ciardi C; Ress C; Tschoner A; Sandhofer A; Paulweber B; Ebenbichler CF; Patsch JR
    Eur J Clin Invest; 2008 Nov; 38(11):827-34. PubMed ID: 19021700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-viral adiponectin gene therapy into obese type 2 diabetic mice ameliorates insulin resistance.
    Park JH; Lee M; Kim SW
    J Control Release; 2006 Aug; 114(1):118-25. PubMed ID: 16797099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients.
    Alberti L; Gilardini L; Girola A; Moro M; Cavagnini F; Invitti C
    Diabetes Obes Metab; 2007 May; 9(3):344-9. PubMed ID: 17391161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic actions of adipocyte hormones: focus on adiponectin.
    Ahima RS
    Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():9S-15S. PubMed ID: 16642957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
    Albert SG; Haas MJ; Mooradian AD
    Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance.
    Straczkowski M; Kowalska I; Nikolajuk A; Otziomek E; Adamska A; Karolczuk-Zarachowicz M; Gorska M
    Int J Obes (Lond); 2007 Feb; 31(2):221-5. PubMed ID: 16770329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes.
    Fang X; Sweeney G
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):798-801. PubMed ID: 17052201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin and cardiovascular disease: response to therapeutic interventions.
    Han SH; Quon MJ; Kim JA; Koh KK
    J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise.
    Vu V; Riddell MC; Sweeney G
    Diabetes Metab Res Rev; 2007 Nov; 23(8):600-11. PubMed ID: 17966120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased levels of plasma adiponectin in prediabetes, Type 2 diabetes and coronary artery disease.
    Yaturu S; Bridges JF; Subba Reddy DR
    Med Sci Monit; 2006 Jan; 12(1):CR17-20. PubMed ID: 16369465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.